Samsung EPIS (KRX:0126Z0) logged an attributable net income of 85.8 billion won for the second quarter, down 14% from the previous three-month period.
No year-over-year comparison is available as the biotechnology company was established on Nov. 3, 2025, and did not exist in the prior-year period, according to a Korea Exchange filing on Friday.
Revenue fell 13% quarter over quarter to 391.9 billion won for the three months ended June 30 from 453.9 billion won in the three months ended April 1.